Bain Capital Public Equity Management’s Gilead Sciences GILD Stock Holding History

Bain Capital Public Equity Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-55,864	Closed	-$4.21M	–	76
2018 Q1	$4.21M	Buy	+55,864	New	+$4.44M	0.31%	47
2017 Q3	–	Sell	-119,780	Closed	-$8.48M	–	71
2017 Q2	$8.48M	Sell	119,780 -7,820	-6%	-$520K	0.51%	37
2017 Q1	$8.67M	Buy	+127,600	New	+$8.97M	0.61%	39
2014 Q1	–	Sell	-647,736	Closed	-$48.6M	–	53
2013 Q4	$48.6M	Sell	647,736 -920,300	-59%	-$64.1M	1.37%	30
2013 Q3	$98.6M	Sell	1,568,036 -2,120,800	-57%	-$127M	2.47%	15
2013 Q2	$189M	Buy	+3,688,836	New	+$192M	4.43%	5

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bain Capital Public Equity Management's GILD Position: Q2 2018 in Review

Bain Capital Public Equity Management sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 55,864 shares — an estimated $4.21M sold.

Bain Capital Public Equity Management first reported a position in GILD in Q2 2013 and held it in 6 quarters. The position peaked at $189M in Q2 2013. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

Bain Capital Public Equity Management reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
Bain Capital Public Equity Management sold 55,864 Gilead Sciences shares in Q2 2018, an estimated $4.21M.
Bain Capital Public Equity Management first reported a position in Gilead Sciences in Q2 2013 and held it in 6 quarters.
Bain Capital Public Equity Management's Gilead Sciences position peaked at $189M in Q2 2013.
1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.